FAK inhibition shows efficacy in mouse models; however, efficacy may be limited due to the overlapping function of family member proline-rich tyrosine kinase 2 (PYK2) and kinase activity independent FAK functions in tumor cells [37]. This evidence concerns the gene PTK2 and neoplasm.